Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Cyst Fibros. 2014 Dec 11;14(3):370–375. doi: 10.1016/j.jcf.2014.11.005

Figure 2. Inhaled antibiotic class utilization among CFFPR patients stratified by age subgroup, lung disease stage, and P. aeruginosa culture status.

Figure 2

Panel A: All CFFPR patients stratified by age group. Panel B: Patients with available FEV1 data stratified by FEV1% predicted group. Panel C: Patients stratified by P. aeruginosa (Pa) culture status during the year. Patients who received only 1 inhaled antibiotic class during the calendar year are shown with gray bars and those receiving >1 inhaled antibiotic class are shown with black bars. For all groups, increases in the proportion of patients receiving >1 inhaled antibiotic class from 2009 to 2012 were statistically significant (P<.001; Table 1).